AtriCure, Inc. (ATRC) Misses Q2 EPS by 1c, Revenue Falls Inline

August 2, 2011 8:49 AM EDT
AtriCure, Inc. (NASDAQ: ATRC) reported Q2 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $16.21 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment